Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Prime Medicine (NASDAQ:PRME) Stock: Rises With the Biotech Bid

Prime Medicine (NASDAQ:PRME) was among the gainers in the US regular session on Thursday, October 15, 2026, climbing as investors rotated into healthcare and biotechnology shares and away from the artificial-intelligence and semiconductor names that dominated the day’s sell-off. The stock closed at $3.61, …

Nitish Kishor | 16 October 2026

OPKO Health (NASDAQ:OPK) Advances on the Day’s Healthcare Bid

OPKO Health (NASDAQ:OPK) was among the gainers in the US regular session on Thursday, October 15, 2026, rising as investors rotated into healthcare shares and away from the artificial-intelligence and semiconductor names that led the day’s sell-off. The stock closed at $1.61, up 17.52% …

Nitish Kishor | 16 October 2026

NeurAxis (NYSE American:NRXS) Stock: Moves Higher Within the Healthcare Theme

NeurAxis (NYSE American:NRXS) was among the gainers in the Thursday, October 15, 2026 US regular session, closing at $7.74 for an advance of 18.53% on the day. The move stood out against a market defined by heavy selling in AI-linked and semiconductor shares, and …

Nitish Kishor | 16 October 2026

Fortrea Holdings (NASDAQ:FTRE) Stock: Gains in the Healthcare-Services Rotation

Fortrea Holdings (NASDAQ:FTRE) advanced on Thursday, October 15, 2026, lifted by the day’s rotation into healthcare-linked shares even as the broader market sagged under a sell-off in AI and semiconductor stocks. The shares closed at $22.75, up 6.58% on the session.

Nitish Kishor | 16 October 2026

Iambic Therapeutics (NASDAQ:IAM) Stock: Post-IPO Gain Stands Out Among Healthcare Names

Iambic Therapeutics (NASDAQ:IAM) was among the standout movers of the Thursday, October 15, 2026 US regular session, closing at $18.91, up 18.19% from a prior close of roughly $16.00. The gain came in a market defined by a deepening sell-off across artificial-intelligence and semiconductor …

Nitish Kishor | 16 October 2026

Indaptus Therapeutics (NASDAQ:INDP) Gains Amid the Healthcare Rotation

Indaptus Therapeutics (NASDAQ:INDP) was among the gainers in the Thursday, October 15, 2026 US regular session, closing at $2.85 for an advance of 28.96% on the day. The move came in a market that was otherwise dominated by a steep sell-off in AI-linked and …

Nitish Kishor | 16 October 2026

Kestra Medical Technologies (NASDAQ:KMTS) Rises on the Healthcare Rotation

Kestra Medical Technologies (NASDAQ:KMTS), a maker of cardiac medical devices, advanced on Thursday, October 15, 2026, closing at $28.68, a gain of 12.60% for the session. The move came on a day when the broad market was under pressure, with the major indexes dragged …

Nitish Kishor | 16 October 2026

Kodiak Sciences (NASDAQ:KOD) Rises With the Healthcare Rotation

Kodiak Sciences (NASDAQ:KOD) gained ground on Thursday, October 15, 2026, in a US session where defensive and healthcare-linked shares drew buyers even as the broader market fell under the weight of an AI and semiconductor sell-off. The stock closed at $88.12, up 8.67% on …

Nitish Kishor | 16 October 2026

Armata Pharmaceuticals (NYSE American:ARMP) Stock: Climbs Amid a Defensive Bid for Healthcare

Armata Pharmaceuticals (NYSE American:ARMP), a micro-cap biotechnology company focused on bacteriophage therapy, rose on Thursday, October 15, 2026, finishing at $3.09, a gain of 11.15% for the session. The advance came during a trading day defined by a sharp retreat in artificial-intelligence and semiconductor …

Nitish Kishor | 16 October 2026

Arcutis Biotherapeutics (NASDAQ:ARQT) Rides the Defensive Healthcare Bid

Arcutis Biotherapeutics (NASDAQ:ARQT) climbed on Thursday, October 15, 2026, closing at $29.10, a gain of 10.19% in a US regular session that otherwise belonged to the sellers. The advance stands out precisely because the broad market did not cooperate: the S&P 500 fell about …

Nitish Kishor | 16 October 2026
Support

Hi! How can we help you today?

Loading…